Row over smallcap mutual fund SIPs: Investors have made double-digit XIRR in 5 years
Investors who continued SIPs in smallcap mutual funds have seen substantial returns despite recent market volatility, with ...
TransCode reports positive phase 1 trial progress for cancer therapy
BOSTON - TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a micro-cap RNA oncology company with a market capitalization of $6.22 million, has announced the progression of its Phase 1 clinical trial with ...